The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis

Abstract

Extracellular matrix (ECM) plays a crucial role in the regulation of both physiological and pathological angiogenesis. ECM homeostasis and function is ensuring by the tightly regulation of the different ECM components including, collagens, proteoglycans and a variety of different glycoproteins. An altered expression of the above ECM molecules as well as an imbalance between the action of matrix remodeling enzymes and their tissue inhibitors is known to be responsible for impaired angiogenesis and fibrosis. Systemic Sclerosis (SSc) is an autoimmune disease characterized by micro-angiopathy, failure of reparative angiogenesis, and excessive fibrosis of the skin and various internal organs, dues to an increased production of ECM. A comprehensive search through Medline/PubMed and Scopus was performed for English-language original papers, using the keywords related to ECM components and SSc. This review will analyze the role played by ECM components in the deregulation of angiogenic mechanisms and in the persistence of a pro-fibrotic phenotype, during SSc. A better knowledge of these processes might provide information about molecules, which could be considered targets for future pro-angiogenic and/or anti-fibrotic therapies.

Plasma Endostatin Correlates with Hypoxia and Mortality in Covid-19-Associated Acute Respiratory Failure

“…For instance, in chronic obstructive pulmonary disease, plasma endostatin was significantly increased in patients with, and strongly associated with disease severity, decreased lung function, increased systemic inflammation and increased number of exacerbations [ 20 , 21 ]. Additionally [ 22 ], patients with pulmonary arterial hypertension have high levels of circulating endostatin [ 22 , 23 ], which correlates to worsened patient outcome.…”

Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering

“…The known trans-differentiation potential of such actively recruited mononuclear blood cells ( 85 – 91 ) and their ability to participate in the intramural cellularisation process and neo-tissue formation of a synthetic scaffold ( 87 ) makes it likely that the entire healing pattern would thus be distinctly different in humans. Ironically, a successful and rapid replacement of a biodegradable scaffold by mature mesenchymal tissue may even prematurely terminate endothelial migration ( 376 ) thereby thwarting transmural surface endothelialisation all together. While the iteration of scaffold chemistry ( 371 , 377 ) and microstructure ( 371 , 378 ) would allow the titration of the degradation process ( 371 , 379 ) the actual clinical requirements against which to titrate remain again poorly defined in the absence of better suited animal models.…”

Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review)

“…growth factor-β (TGFβ), and the recruitment of ecs into injured tissue may be ecM protein-dependent (14)(15)(16). in addition, a strong correlation has been revealed between microvascular dysregulation and fibrosis (2); in fact, abnormal microvasculature structure is a characteristic of FPds that is associated with endothelial swelling, necrosis, pericyte detachment and thickening of the vascular basement membrane (17)(18)(19).…”